MedTrace Logo

A Short-Term Study to Examine the Effects of ATHX-105 Phosphate on Weight Loss and Safety

NCT00735683 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2015-06-02

No results posted yet for this study

Summary

This primary purpose of this study is to determine if ATHX-105 phosphate causes weight loss over a 12-week period.

Conditions

Interventions

DRUG

ATHX-105 phosphate

includes diet, physical activity, and lifestyle modification

DRUG

Placebo

includes diet, physical activity, and lifestyle modification

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2009-04-30
Completion
2009-04-30

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00735683 on ClinicalTrials.gov